Uche Ndidi | Data Visualization | Best Researcher Award

Published on by Research Data Analysis

Assoc. Prof. Dr. Uche Ndidi | Data Visualization | Best Researcher Award

Ahmadu Bello University | Nigeria

Dr. Uche Samuel Ndidi is an Associate Professor in the Department of Biochemistry at Ahmadu Bello University, Zaria, Nigeria, with over 15 years of academic experience. He earned a BSc in Applied Biochemistry from Nnamdi Azikiwe University, Awka, Nigeria (2004), an MSc in Biochemistry from Ahmadu Bello University, Zaria, Nigeria (2009), and completed his PhD in Biotechnology in Health and Investigative Medicine at the Instituto Gonçalo Moniz-Fundação Oswaldo Cruz (FIOCRUZ), Brazil (2013), and is currently pursuing postdoctoral research in Human Pathology at FIOCRUZ (2024). His research focuses on medical biochemistry, with emphasis on sickle cell disease, type 2 diabetes mellitus, trypanosomiasis, and neglected tropical diseases, employing advanced techniques such as PCR, ELISA, HPLC, and flow cytometry. He has authored over 23 publications, with numerous citations, and has supervised both undergraduate and postgraduate students. Dr. Ndidi serves as the Postgraduate Coordinator in the Department of Biochemistry at ABU and as the Student Internship Officer of the African Centre of Excellence in Neglected Tropical Diseases and Forensic Biotechnology (ACENTDFB), and is a member of the Nigerian Society of Biochemistry and Molecular Biology and the Science Association of Nigeria. His work has been recognized with the Oswaldo Cruz Foundation (FIOCRUZ) Scholarship and the Brazil National Council for Scientific and Technological Development (CNPq) Scholarship. Dr. Ndidi’s extensive research and leadership have advanced the understanding and management of key biochemical and medical conditions, particularly in African populations.

Profiles : Orcid | Scopus | Google Scholar

Featured Publications

Ndidi, U.S.; Ogwuche O.I.; Jonathan, E.U.; Iroha, O.K. (2025). “Drug repurposing in cancer research: a bibliometric analysis.” Discover Oncology.

Ndidi, U.S.; Adanho, C.S.A.; Santiago, R.P.; Yahouédéhou, S.C.M.A.; Santana, S.S.; Mafili, V.V.; Pitanga, T.N.; Fonseca, C.A.; Ferreira, J.R.D.; Adorno, E.V. et al. (2019). “Effect of N(Epsilon)-(carboxymethyl)lysine on laboratory parameters and its association with βS haplotype in children with sickle cell anemia.” Disease Markers.

Okpe, O.; Ndidi, U.S.; Ojowu, J.; Maifada, S.R.; Etim, E.E.; Awen, D.A.; Ovur, C.E. (2019). “GC–MS profiling and antimalarial activity of Khaya grandifoliola on Plasmodium berghei–infected mice.” Journal of Herbs, Spices and Medicinal Plants.

Yahouédéhou, S.C.M.A.; da Guarda, C.C.; Figueiredo, C.V.B.; Santiago, R.P.; Carvalho, S.P.; Fiuza, L.M.; Ndidi, U.S.; Oliveira, R.M.; Carvalho, M.O.S.; Nascimento, V.M.L. et al. (2019). “Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: investigating associations with βS haplotype and α-thalassemia.” PLoS ONE.

Yahouédéhou, S.C.M.A.; Adorno, E.V.; da Guarda, C.C.; Ndidi, U.S.; Carvalho, S.P.; Santiago, R.P.; Aleluia, M.M.; de Oliveira, R.M.; Gonçalves, M.S. (2018). “Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism.” Pharmacogenomics Journal.

 

Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Prof. Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Jinzhou Medical University | China

Prof. Jia Liang, Ph.D., is a distinguished neuroscientist and professor-level senior experimentalist at the Life Science Institute of Jinzhou Medical University, China. With over a decade of focused research in the field of neurobiology, her scientific journey has been defined by groundbreaking contributions to the understanding of cerebral ischemic injury and neuroprotection. Her work is widely recognized both nationally and internationally, marked by a robust portfolio of funded research projects, prolific publications, and collaborative engagements in translational neuroscience.

Professional Profile

SCOPUS

Education

Prof. Liang began her academic pursuit with a Bachelor’s degree in Clinical Medicine from Jinzhou Medical College. She further specialized in Physiology with a Master’s degree from Liaoning Medical University. Demonstrating a deep commitment to neurological sciences, she later completed her Ph.D. in Neurobiology from Capital Medical University in Beijing, where she developed her foundational expertise in molecular and cellular mechanisms underlying stroke-related brain injury.

Experience

Her professional career commenced as an Assistant Experimentalist at the Central Laboratory of Jinzhou Medical University, where she quickly ascended the ranks to become a Senior Experimentalist and eventually a Professor-level Senior Experimentalist at the university’s Life Science Institute. She also broadened her international exposure during her post-doctoral fellowship at the Health Science Centre of the University of New Mexico in the United States, where she engaged in advanced neuroscience research. Throughout her tenure, Prof. Liang has been deeply involved in mentoring students, managing laboratory operations, and leading numerous high-impact research projects on stroke and neural injury.

Research Interest

Prof. Liang’s primary research interests lie in the molecular mechanisms of brain injury and neuroprotection, especially within the context of cerebral ischemia. Her work explores the role of zinc in brain-to-spleen immune pathways, blood-brain barrier integrity, autophagy, ferroptosis, and the application of stem cell-derived exosomes in stroke therapy. A key focus of her research is understanding the neurovascular unit’s dynamics and identifying new biomarkers and therapeutic targets for ischemic injury. Her innovative use of nanotechnology, exosome biology, and targeted gene/protein modulation has significantly contributed to modern stroke therapeutics and regenerative neurology.

Award and Funding

Prof. Liang has received consistent research funding from prestigious sources, including the National Natural Science Foundation of China and the Natural Science Foundation of Liaoning Province.  She has also secured institutional and educational department grants focused on neuroprotection through mesenchymal stem cell-derived exosomes and the modulation of oxidative stress pathways. Her funding portfolio reflects both her scientific credibility and the practical relevance of her research in addressing pressing neurological health issues.

Publications

Brain Targeting Bacterial Extracellular Vesicles Enhance Ischemic Stroke Therapy via Efficient ROS Elimination and Suppression of Immune Infiltration

  • Authors: [Names not provided – please insert from source]

  • Journal: ACS Nano

  • Year: 2025

Indoleamine 2,3-dioxygenase-1 Involves in CD8⁺ T Cell Exhaustion in Glioblastoma via Regulating Tryptophan Levels

  • Authors: [Names not provided – please insert from source]

  • Journal: International Immunopharmacology

  • Year: 2024

β-1,4-Galactosyltransferase 1 Protects Against Cerebral Ischemia Injury in Mice by Suppressing Ferroptosis via the TAZ/Nrf2/HO-1 Signaling Pathway

  • Authors: [Names not provided – please insert from source]

  • Journal: CNS Neuroscience and Therapeutics

  • Year: 2024

Conclusion

Prof. Jia Liang stands at the forefront of experimental neurobiology with her comprehensive, multidisciplinary approach to stroke research. Her expertise spans molecular biology, immunology, stem cell therapy, and nanomedicine, allowing her to tackle complex neurovascular disorders with innovation and precision. With an extensive publication record in high-impact journals and an ever-expanding research network, she continues to influence the global neuroscience community through her discoveries, mentorship, and scientific leadership. Her future work promises to further unravel the intricacies of brain injury and recovery, ultimately paving the way for more effective treatments for stroke and related neurological conditions.

Ahmed Abdellatif – Nanotechnology – Best Researcher Award 

Published on by Research Data Analysis

Dr. Ahmed Abdellatif - Nanotechnology - Best Researcher Award 

Qassim University - Saudi Arabia

Author Profile

Early Academic Pursuits

Dr. Ahmed Abdellatif's academic journey commenced with a Bachelor of Pharmaceutical Sciences from Al-Azhar University, Egypt, where his dissertation focused on the formulation and evaluation of various microspheres as a drug delivery system. He proceeded to obtain his Master of Pharmaceutical Technology from the same institution, delving deeper into formulation science. His thesis concentrated on colon targeting using 5-FU microsponge, showcasing an early interest in targeted drug delivery systems. His academic pursuits culminated in a PhD in Pharmaceutical Technology from Regensburg University, Germany. His doctoral research involved the formulation and characterization of nanoparticles targeting somatostatin receptors, demonstrating his commitment to cutting-edge drug delivery technologies.

Professional Endeavors

Dr. Ahmed Abdellatif's professional journey spans various academic and research roles across prestigious institutions. Starting as a Teaching Assistant of Pharmaceutics and Industrial Pharmacy at Al-Azhar University, Egypt, he gradually progressed through the ranks, serving as an Assistant Lecturer and later as an Assistant Professor. He further expanded his academic footprint by working as a Part-Time Lecturer at multiple universities in Egypt. His international experience includes a stint as a PhD student at the University of Regensburg, Germany, where he honed his research skills in pharmaceutical technology. Currently, he holds the esteemed position of Associate Professor of Pharmaceutics at both Qassim University, Saudi Arabia, and Al-Azhar University, Egypt.

Contributions and Research Focus

Dr. Ahmed Abdellatif's research endeavors revolve around drug targeting and delivery, with a particular emphasis on nanoparticle-based systems. His work spans the synthesis and characterization of various nanoparticles for targeted drug delivery applications, including cancer therapy. Notably, he has explored receptor targeting strategies and conducted in-depth studies on cellular uptake mechanisms. His research contributions extend to the formulation of nanoparticles for ocular and dermatological applications, showcasing the breadth of his expertise in pharmaceutical sciences.

Accolades and Recognition

Dr. Ahmed Abdellatif's contributions to the field of pharmaceutical sciences have garnered significant recognition, including being ranked among the world's top 2% of scientists by Stanford citation analysis. He has served as an Associate Editor and Academic Editor for prestigious journals in the field, demonstrating his standing as a thought leader and expert in pharmaceutics and drug delivery. Additionally, his involvement in organizing international conferences underscores his leadership qualities and commitment to advancing pharmaceutical education and research.

Impact and Influence

Through his research, publications, and academic endeavors, Dr. Ahmed Abdellatif has made a substantial impact on the field of pharmaceutical technology. His work has contributed to advancing the understanding of nanoparticle-based drug delivery systems and their potential applications in targeted therapy. By mentoring and supervising numerous master's and doctoral students, he has nurtured the next generation of pharmaceutical scientists, ensuring a lasting legacy of excellence and innovation in the field.

Legacy and Future Contributions

Looking ahead, Dr. Ahmed Abdellatif continues to spearhead groundbreaking research in pharmaceutical technology, with a focus on addressing unmet medical needs through innovative drug delivery approaches. His commitment to excellence, coupled with his collaborative spirit and leadership qualities, positions him as a key figure in shaping the future of pharmaceutics. As he continues to push the boundaries of scientific discovery and mentor aspiring researchers, his legacy as a visionary in drug delivery science is destined to endure for years to come.

Citations

A total of  2243 citations for his publications, demonstrating the impact and recognition of her research within the academic community.

  • Citations    2243
  • h-index       25
  • i10-index    69

Notable Publication

 

 

Nad Siroros | Best Researcher Award | Biomedical Engineering

Published on by Research Data Analysis

Nad Siroros | Best Researcher Award  Winner 2023  🏆

Mr Nad Siroros : Biomedical Engineering

Congratulations to Mr. Nad Siroros, Biomedical Engineering expert, on winning the Best Researcher Award at the International Research Data Analysis Excellence Awards. This prestigious accolade recognizes his outstanding contributions and excellence in the field. Well done, Mr. Siroros, on this remarkable achievement!

Professional profile:

Early Academic Pursuits:

Nad Siroros embarked on his academic journey with a strong foundation in Mechanical Engineering. His undergraduate studies, completed in 2012 at Chiang Mai University, Thailand, were complemented by international exposure, including a visiting student stint at the School of Energy and Power Engineering, Jiangsu University, China, in 2012. This early international experience set the stage for his future endeavors in the field.

Professional Endeavors:

In 2015, Nad earned a Master of Engineering in Biomedical Engineering from Chiang Mai University. This marked a pivotal moment in his academic career as he transitioned into the specialized realm of biomedical engineering. Following this, he undertook co-operative education at the French Institute for Advanced Mechanics (IFMA) in 2010, showcasing his commitment to diverse and comprehensive learning experiences.

Contributions and Research Focus:

From January 2016 to May 2019, Nad engaged in groundbreaking research at the Chair of Medical Engineering (mediTec), Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Germany. His work at this prestigious institute underscored his dedication to the intersection of engineering and medicine. Subsequently, from June 2019 to December 2023, he continued his impactful contributions in the Research Laboratory, specifically the Working Group Clinical and Experimental Orthopaedics Biomechanics, Department of Orthopaedics, Trauma, and Reconstructive Surgery at Uniklinik RWTH Aachen.

Nad's research has been primarily focused on experimental biomechanics, biomechanical modeling, and simulation. His specialization in the design of implants, prostheses, and medical devices showcases a commitment to advancing medical technology and improving patient outcomes.

Accolades and Recognition:

Throughout his academic and professional journey, Nad Siroros has undoubtedly garnered recognition for his exceptional contributions. While specific accolades may not be detailed, the pursuit of a Doctor of Theoretical Medicine at the Faculty of Medicine, RWTH Aachen University, Germany, signifies acknowledgment of his capabilities and potential in the field.

Impact and Influence:

Nad's impact is evident in the institutions and research groups where he has been actively involved. His work has likely contributed to advancements in clinical and experimental orthopaedics biomechanics, leaving a lasting impression on the academic and medical communities.

Legacy and Future Contributions:

As Nad moves towards completing his Doctor of Theoretical Medicine, his legacy in the field of biomechanics and biomedical engineering is solidifying. The interdisciplinary nature of his work suggests a future where his contributions will continue to bridge the gap between engineering and medicine, paving the way for innovative solutions in healthcare.

In summary, Nad Siroros's academic and professional journey is marked by a seamless integration of international experiences, a commitment to research excellence, and a focus on advancing medical technology. His legacy is poised to endure through ongoing and future contributions to the field of theoretical medicine.

Notable publication :

Citations:

A total of  16 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations    16
  • h-index        3